Moreover, therapeutic approaches targeting HKDC1 are expected to improve cancer treatment outcomes by intervening in tumor metabolism and enhancing the tumor immune microenvironment, making it an important focus for future cancer metabolic interventions and immunotherapy. The gene discussed is HKDC1; the disease is neoplasm.